University of Georgia Hajduk Lab Awarded IMS and Riney Foundation Translational Research Grant

The University of Georgia’s Hajduk Lab has been awarded a $250,000 International Myeloma Society (IMS) and Paula and Rodger Riney Foundation Translational Research Grant supporting translational research in multiple myeloma connected to Annate Bitherapeutics’ platform.

The award will support work in the Hajduk Lab at the University of Georgia for the continued translational development of a targeted biologic platform for multiple myeloma. According to Annate co-founder and CEO Eric DeJesus, PhD, the supported studies will focus on efficacy, mechanism, and combination strategies relevant to relapsed and refractory disease.

The IMS and Paula and Rodger Riney Foundation Translational Research Award supports investigator-initiated translational research in plasma cell disorders, including multiple myeloma. IMS describes the program as supporting research intended to advance prevention, early detection, diagnosis, and treatment of plasma cell disorders.

Dr. DeJesus noted that the support from IMS and the Paula and Rodger Riney Foundation represents an important step in building the translational data package needed to further de-risk and advance the platform.

Annate is grateful to IMS, the Paula and Rodger Riney Foundation, and the collaborators and advisors supporting this multiple myeloma research, including Drs. Ajay Nooka and Vikas Gupta, advisor Dr. Gregory Lesinski, Winship Cancer Institute of Emory University, and the University of Georgia Innovation District.

Read more: Eric DeJesus, PhD on LinkedIn

Learn more about the grant program: IMS and Paula and Rodger Riney Foundation Translational Research Award